Published in Br J Radiol on August 01, 1995
Autophagy Inhibition to Increase Radiosensitization in Breast Cancer. J Nucl Med Radiat Ther (2015) 0.77
Effect of image-guided hypofractionated stereotactic radiotherapy on peripheral non-small-cell lung cancer. Onco Targets Ther (2016) 0.75
The application of the linear-quadratic dose-effect equation to fractionated and protracted radiotherapy. Br J Radiol (1985) 3.17
Nitrogen-containing metabolites from marine cyanobacteria. Alkaloids Chem Biol (2001) 2.21
An audit of delays before and during radical radiotherapy for cervical cancer--effect on tumour cure probability. Clin Oncol (R Coll Radiol) (2003) 1.81
An audit of clinic consultation times in a cancer centre: implications for national manpower planning. Clin Oncol (R Coll Radiol) (2001) 1.53
The role of biologically effective dose (BED) in clinical oncology. Clin Oncol (R Coll Radiol) (2001) 1.35
A modelled comparison of the effects of using different ways to compensate for missed treatment days in radiotherapy. Clin Oncol (R Coll Radiol) (1996) 1.31
Intra-tumour genetic heterogeneity and poor chemoradiotherapy response in cervical cancer. Br J Cancer (2010) 1.13
Fast neutron relative biological effects and implications for charged particle therapy. Br J Radiol (2011) 1.13
Antibody distribution and dosimetry in patients receiving radiolabelled antibody therapy for colorectal cancer. Br J Cancer (1989) 1.12
A four-dimensional computer simulation model of the in vivo response to radiotherapy of glioblastoma multiforme: studies on the effect of clonogenic cell density. Br J Radiol (2006) 1.12
The effects of delays in radiotherapy treatment on tumour control. Phys Med Biol (2003) 1.11
Mathematical models of tumour and normal tissue response. Acta Oncol (1999) 1.07
The assessment of the body distribution of yttrium-90 ferric hydroxide during radiation synovectomy. Br J Radiol (1976) 1.07
Repeated antitumour antibody therapy in man with suppression of the host response by cyclosporin A. Br J Cancer (1988) 1.06
A novel algorithm for the morphometric assessment of radiotherapy treatment planning volumes. Br J Radiol (2009) 1.02
Calculation of high-LET radiotherapy dose required for compensation of overall treatment time extensions. Br J Radiol (2006) 1.02
Contrast enhanced dynamic MRI of cervical carcinoma during radiotherapy: early prediction of tumour regression rate. Br J Radiol (1999) 0.98
Transmuscular migration of solid silicone band. Eye (Lond) (2007) 0.92
Comparison of RIPASA and Alvarado scores for the diagnosis of acute appendicitis. Singapore Med J (2011) 0.91
A theoretical investigation into the role of tumour radiosensitivity, clonogen repopulation, tumour shrinkage and radionuclide RBE in permanent brachytherapy implants of 125I and 103Pd. Phys Med Biol (2001) 0.91
The potential for mathematical modelling in the assessment of the radiation dose equivalent of cytotoxic chemotherapy given concomitantly with radiotherapy. Br J Radiol (2005) 0.89
Innovations in continuing professional development--countering the Dunning-Kruger effect. Clin Oncol (R Coll Radiol) (2011) 0.88
Comments on Inadequacy of iridium implant as sole radiation treatment for operable breast cancer, Fentiman et al., Eur J Cancer 1996, 32A, pp. 608-611. Eur J Cancer (1997) 0.87
Fractionation effects in particle radiotherapy: implications for hypo-fractionation regimes. Phys Med Biol (2010) 0.87
Active minimisation of radiation scatter during breast radiotherapy: management implications for young patients with good-prognosis primary neoplasms. Radiother Oncol (1996) 0.87
The potential impact of relative biological effectiveness uncertainty on charged particle treatment prescriptions. Br J Radiol (2011) 0.87
Cell loss factors and the linear-quadratic model. Radiother Oncol (1995) 0.86
Determination of tumour regression rates during radiotherapy for cervical carcinoma by serial MRI: comparison of two measurement techniques and examination of intraobserver and interobserver variability. Br J Radiol (1999) 0.85
Biological equivalent dose assessment of the consequences of hypofractionated radiotherapy. Int J Radiat Oncol Biol Phys (2000) 0.85
Alterations in classical and nonclassical HLA expression in recurrent and progressive HPV-induced usual vulvar intraepithelial neoplasia and implications for immunotherapy. Int J Cancer (2014) 0.84
Use of second antibody in radioimmunotherapy. NCI Monogr (1987) 0.84
Concurrent weekly cisplatin chemotherapy and radiotherapy in a haemodialysis patient with locally advanced cervix cancer. Clin Oncol (R Coll Radiol) (2008) 0.82
Chronic myeloid leukemia with e19a2 (c3a2) BCR/ABL fusion junction--is it truly a benign disease? Leukemia (1998) 0.82
Molecular and phenotypic spectrum of de novo Philadelphia positive acute leukemia. Int J Mol Med (1999) 0.82
High dose rate brachytherapy practice for the treatment of gynaecological cancers in the UK. Br J Radiol (1999) 0.82
Final results of the Royal College of Radiologists' trial comparing two different radiotherapy schedules in the treatment of cerebral metastases. Clin Oncol (R Coll Radiol) (1997) 0.82
Radiotherapy treatment delays and their influence on tumour control achieved by various fractionation schedules. Br J Radiol (2008) 0.81
Some theoretical derivations relating to the tissue dosimetry of brachytherapy nuclides, with particular reference to iodine-125. Med Phys (1983) 0.81
Results of a questionnaire regarding the practice of radiotherapy for carcinoma of the cervix in the UK. Br J Radiol (1994) 0.80
The reduction of tumour control with increasing overall time: mathematical considerations. Br J Radiol (1996) 0.80
Radiobiological modelling of dose-gradient effects in low dose rate, high dose rate and pulsed brachytherapy. Phys Med Biol (2006) 0.80
Determination of the optimum dose per fraction in fractionated radiotherapy when there is delayed onset of tumour repopulation during treatment. Br J Radiol (2004) 0.80
Uncomplicated diverticular disease is not a common cause of colonic symptoms. Aliment Pharmacol Ther (2010) 0.80
Particle radiotherapy in the UK. Clin Oncol (R Coll Radiol) (2007) 0.80
Estimation of optimum dose per fraction for high LET radiations: implications for proton radiotherapy. Int J Radiat Oncol Biol Phys (2000) 0.80
Radiation-induced malignant melanoma of the cervix. Clin Oncol (R Coll Radiol) (2000) 0.79
Radiobiological modeling and clinical trials. Int J Radiat Oncol Biol Phys (2000) 0.79
Repair kinetic considerations in particle beam radiotherapy. Br J Radiol (2011) 0.78
Radiobiological compensation of treatment errors in radiotherapy. Br J Radiol (2008) 0.78
A graphical method to simplify the application of the linear-quadratic dose-effect equation to fractionated radiotherapy. Br J Radiol (1986) 0.78
Radiobiological prediction of normal tissue toxicities and tumour response in the radiotherapy of advanced non-small-cell lung cancer. Br J Cancer (1998) 0.78
Treatment of localized carcinoma of the penis: a survey of current practice in the UK. Clin Oncol (R Coll Radiol) (2001) 0.78
Inclusion of molecular biotherapies with radical radiotherapy: modeling of combined modality treatment schedules. Int J Radiat Oncol Biol Phys (1999) 0.78
The potential of ytterbium 169 in brachytherapy: a brief physical and radiobiological assessment. Br J Radiol (1992) 0.78
Two patients with novel BCR/ABL fusion transcripts (e8/a2 and e13/a2) resulting from translocation breakpoints within BCR exons. Br J Haematol (1999) 0.78
Radiobiologically based assessments of the net costs of fractionated focal radiotherapy. Int J Radiat Oncol Biol Phys (1998) 0.77
Brachiocephalic-superior vena cava metallic stenting in malignant superior vena cava obstruction. Ann Acad Med Singapore (2003) 0.76
Bevacizumab (Avastin) as a surgical adjunct in diabetic vitrectomy for fibrovascular disease. Eye (Lond) (2008) 0.76
Theoretical implications of incorporating relative biological effectiveness into radiobiological equivalence relationships. Br J Radiol (2013) 0.75
Comment on "Analysis of factors affecting the therapeutic gain in high dose rate gynecological implants relative to low dose rate implants" [Med. Phys. 23, 419-425 (1996)]. Med Phys (1996) 0.75
The BJR and progress in radiobiological modelling. Br J Radiol (2010) 0.75
Regarding Giap and Massullo, IJROBP 1999;45:1355-1358. Int J Radiat Oncol Biol Phys (2000) 0.75
Chemoradiotherapy for cervical cancer--do questions remain? Clin Oncol (R Coll Radiol) (2010) 0.75
Conventional wisdom and activities of the middle range. Br J Radiol (2005) 0.75
HDR versus LDR gynaecological brachytherapy revisited. Radiother Oncol (1994) 0.75
Pulsed brachytherapy: a modelled consideration of repair parameter uncertainties and their influence on treatment duration extension and daytime-only "block-schemes". Br J Radiol (2011) 0.75
Implications of overall time in radiotherapy. Clin Oncol (R Coll Radiol) (1993) 0.75
A theoretical investigation into post-operative, intracavitary beta therapy of high-grade glioblastomas using yttrium-90. Phys Med Biol (2006) 0.75
A Fortran program for fast and compact processing of clinical radiotherapy data. Comput Biol Med (1984) 0.75
Non-uniform dwell times in line source high dose rate brachytherapy: physical and radiobiological considerations. Br J Radiol (1994) 0.75
Implementation of the Philips treatment planning system for use in radiation teletherapy. Br J Radiol (1978) 0.75
Estimation of tumour hypoxic fraction from clinical data sets compatible with accelerated repopulation. Acta Oncol (1998) 0.75
The incorporation of specific tissue/nuclide attenuation data into the Anderson method for producing brachytherapy volume-dose histograms. Phys Med Biol (1990) 0.75
The effect of bruised beef addition on the quality of processed meat products. Meat Sci (1993) 0.75
Quality control of linear accelerator x-ray performance using semiconductor probes. Radiology (1985) 0.75
A Monte Carlo derivation of parameters for use in the tissue dosimetry of medium and low energy nuclides. Br J Radiol (1982) 0.75
Philadelphia positive acute lymphoblastic leukaemia (ALL): clinico-haematologic characteristics, molecular analyses and 3-year follow up--a single institution study. Ann Acad Med Singapore (2000) 0.75
Case report: low dose rate and high dose rate intracavitary brachytherapy in a patient with carcinoma of the cervix. Br J Radiol (1996) 0.75
The influence of air cavities on the optic chiasm dose during pituitary radiotherapy for acromegaly. Br J Radiol (1996) 0.75
Between-technician variation in the measurement of spirometry with air and helium. Am Rev Respir Dis (1981) 0.75
Calculation by computer of dose distributions for superficial gold-198 implants and the derivation of optimized distribution rules. Br J Radiol (1976) 0.75
Radial dose function (RDF) Int J Radiat Oncol Biol Phys (1989) 0.75
Proceedings: The relationship between iso-effect dose and overall irradiation time in an organized tissue. Br J Radiol (1975) 0.75
The achievement of isoeffective bronchial mucosal dose during endobronchial brachytherapy. Int J Radiat Oncol Biol Phys (1995) 0.75
Accelerated fractionation (AF) in head and neck cancers. Radiother Oncol (1998) 0.75
An elastically compressible phantom material with mechanical and x-ray attenuation properties equivalent to breast tissue. Phys Med Biol (2010) 0.75
Plasma TGFbeta1 during pelvic radiotherapy for gynaecological malignancy. Acta Oncol (2006) 0.75
Revisions to radial dose function data for 125I and 131Cs. Med Phys (1987) 0.75
Radiobiology of changes in dose-rate. Sonderb Strahlenther Onkol (1988) 0.75
Gynaecological brachytherapy: a 1 day seminar organized by the British Institute of Radiology Brachytherapy Working Party. Br J Radiol (2004) 0.75
BED-time charts and their application to the problems of interruptions in external beam radiotherapy treatments. Int J Radiat Oncol Biol Phys (1999) 0.75
Radiobiological compensation for unintended treatment interruptions during palliative radiotherapy. Br J Radiol (2007) 0.75
A mathematical model of intraluminal and intracavitary brachytherapy. Br J Radiol (1994) 0.75
Acupuncture therapy: current Chinese practice. Geriatrics (1973) 0.75